Y. Koopman-Keemink

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

François Prince, Marinka Twilt, R. ten Cate et al. · Annals of the Rheumatic Diseases · 2008 · 211 citations · Full text

Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis

M.H. Otten, Femke H. M. Prince, Wineke Armbrust et al. · JAMA · 2011 · 143 citations · Full text

Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study

Federico Martinón‐Torres, Antonio Salas, Irene Rivero‐Calle et al. · The Lancet Child & Adolescent Health · 2018 · 85 citations · Full text

Pediatric Epidemiology, Healthcare-associated Infection, Pediatrics +9

Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial

Petra Müller, D. M. C. Brinkman, Dieneke Schonenberg‐Meinema et al. · Annals of the Rheumatic Diseases · 2018 · 83 citations

Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010

M.H. Otten, Femke H. M. Prince, Marinka Twilt et al. · The Journal of Rheumatology · 2011 · 72 citations · Full text